Yale University Professor Harvey Risch says all studies which study the effectiveness of hydroxychloroquine on high risk population groups show the drug is “uniformly beneficial” in treating COVID-19.
Studies show hydroxychloroquine cuts ‘virus mortality in half …/ By Dr. Risch/ Sky News
